Tetrabenazine for treatment of chorea associated with Huntington's disease and other potential indications

Tetrabenazine Treatment for Stereotypies and Tics Associated With Dementia

(2013) William G. Ondo   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Brain Dopamine–Serotonin Vesicular Transport Disease and Its Treatment

(2013) Jennifer J. Rilstone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature

(2012) Jack J. Chen et al.   CLINICAL THERAPEUTICS

Therapeutics in Huntington’s Disease

(2012) Annie Killoran et al.   Current Treatment Options in Neurology

Huntington's disease: How intermediate are intermediate repeat lengths?

(2012) Ferdinando Squitieri et al.   MOVEMENT DISORDERS

The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis

(2012) Tamara Pringsheim et al.   MOVEMENT DISORDERS

Huntington's disease: Objective assessment of posture-A link between motor and functional deficits

(2012) Ralf Reilmann et al.   MOVEMENT DISORDERS

Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis

(2012) James T. Teo et al.   MOVEMENT DISORDERS

Analysis ofCYP2D6genotype and response to tetrabenazine

(2012) Raja Mehanna et al.   MOVEMENT DISORDERS

Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology

(2012) M. J. Armstrong et al.   NEUROLOGY

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

(2012) J.- M. Lee et al.   NEUROLOGY

Effect of tetrabenazine on computerized dynamic posturography in Huntington disease patients

(2012) Robert Fekete et al.   PARKINSONISM & RELATED DISORDERS

Characterization of a Large Group of Individuals with Huntington Disease and Their Relatives Enrolled in the COHORT Study

(2012) E. Ray Dorsey et al.   PLoS One

Postthalamic Stroke Dystonic Choreoathetosis Responsive to Tetrabenazine

(2011) Rocco Salvatore Calabrò et al.   ANNALS OF PHARMACOTHERAPY

Differential Diagnosis of Chorea

(2011) Ruth H. Walker   Current Neurology and Neuroscience Reports

Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders

(2011) Joseph Jankovic et al.   Expert Review of Neurotherapeutics

Tetrabenazine Augmentation in Treatment-Resistant Schizophrenia

(2011) Gary Remington et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Development of biomarkers for Huntington's disease

(2011) David W Weir et al.   LANCET NEUROLOGY

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

(2011) Justo Garcia de Yebenes et al.   LANCET NEUROLOGY

Milestones in Huntington disease

(2011) Ira Shoulson et al.   MOVEMENT DISORDERS

Pharmacologic approaches to the treatment of Huntington's disease

(2011) Charles S. Venuto et al.   MOVEMENT DISORDERS

Assessment of involuntary choreatic movements in Huntington's disease-Toward objective and quantitative measures

(2011) Ralf Reilmann et al.   MOVEMENT DISORDERS

An evidence-based approach in the treatment of Huntington’s disease

(2011) T.A. Mestre et al.   PARKINSONISM & RELATED DISORDERS

Neurodegenerative processes in Huntington's disease

(2011) D Bano et al.   Cell Death & Disease

Dopamine and Glutamate in Huntington's Disease: A Balancing Act

(2010) Véronique M. André et al.   CNS Neuroscience & Therapeutics

Advances in the Pharmacological Management of Huntingtonʼs Disease

(2010) Samuel Frank et al.   DRUGS

Long-term follow-up of pallidal deep brain stimulation in two cases of Huntington's disease

(2010) G. A. Kang et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Huntington's disease: from molecular pathogenesis to clinical treatment

(2010) Christopher A Ross et al.   LANCET NEUROLOGY

Tetrabenazine is neuroprotective in Huntington's disease mice

(2010) Hongyu Wang et al.   Molecular Neurodegeneration

Tardive dyskinesia and other movement disorders secondary to aripiprazole

(2010) Maria Sierra Peña et al.   MOVEMENT DISORDERS

Earliest functional declines in Huntington disease

(2010) Leigh J. Beglinger et al.   PSYCHIATRY RESEARCH

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

(2009) Samuel Frank   BMC Neurology

Tetrabenazine

(2009) Alfonso Fasano et al.   EXPERT OPINION ON PHARMACOTHERAPY

A pilot study using nabilone for symptomatic treatment in Huntington's disease

(2009) Adrienne Curtis et al.   MOVEMENT DISORDERS

Tourette Syndrome

(2009) Joohi Jimenez-Shahed   NEUROLOGIC CLINICS

Tourette??s Syndrome and Role??of??Tetrabenazine

(2008) Mauro Porta et al.   CLINICAL DRUG INVESTIGATION

A Study of Chorea After Tetrabenazine Withdrawal in Patients With Huntington Disease

(2008) Samuel Frank et al.   CLINICAL NEUROPHARMACOLOGY

Mechanisms of neurodegeneration in Huntington’s disease

(2008) Joana M. Gil et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II

(2008) Alexandra Benchoua et al.   HUMAN MOLECULAR GENETICS

Comparison of Weight Gain in Treatments for Tourette Syndrome: Tetrabenazine Versus Neuroleptic Drugs

(2008) William G. Ondo et al.   JOURNAL OF CHILD NEUROLOGY

Falls and gait disturbances in Huntington's disease

(2008) Yvette A.M. Grimbergen et al.   MOVEMENT DISORDERS

Health-related quality of life in Huntington's disease: Which factors matter most?

(2008) Aileen K. Ho et al.   MOVEMENT DISORDERS